Should Ki-67 be adopted to select breast cancer patients for treatment with adjuvant abemaciclib?
Saved in:
| Title: | Should Ki-67 be adopted to select breast cancer patients for treatment with adjuvant abemaciclib? |
|---|---|
| Authors: | Tarantino, P.1,2,3,4 (AUTHOR), Burstein, H.J.3,4 (AUTHOR), Lin, N.U.3,4 (AUTHOR), Krop, I.E.3,4 (AUTHOR), Winer, E.P.3,4 (AUTHOR), Schnitt, S.J.3,4,5 (AUTHOR), Hamilton, E.P.6 (AUTHOR), Hurvitz, S.A.7 (AUTHOR), Rugo, H.S.8 (AUTHOR), Curigliano, G.1,2 (AUTHOR), Tolaney, S.M.3,4 (AUTHOR) Sara_Tolaney@dfci.harvard.edu |
| Source: | Annals of Oncology. Mar2022, Vol. 33 Issue 3, p234-238. 5p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2021.12.004 |
